Lanatoside C ameliorates DSS-induced colitis with improved intestinal barrier integrity and reduced M1 macrophage polarization

Key Points

• Lanatoside C ameliorates DSS-induced colitis, enhancing gut health and barrier function.
• The treatment notably reduced M1 macrophage polarization, which is linked to inflammation.
• Analysis focused on changes in intestinal barrier integrity and inflammatory responses in a colitis model.
• These findings support the potential role of lanatoside C in treating inflammatory bowel disease.